ACIT-1
/ Cancer Vaccines Limited
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 21, 2026
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
(clinicaltrials.gov)
- P1/2 | N=34 | Active, not recruiting | Sponsor: Cancer Vaccines Limited | Trial completion date: Feb 2026 ➔ Jul 2027 | Trial primary completion date: May 2025 ➔ Dec 2026
Trial completion date • Trial primary completion date • Hematological Malignancies • Oncology
February 26, 2024
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
(clinicaltrials.gov)
- P1/2 | N=34 | Active, not recruiting | Sponsor: Cancer Vaccines Limited | Trial completion date: Feb 2025 ➔ Feb 2026 | Trial primary completion date: Apr 2024 ➔ Apr 2025
Trial completion date • Trial primary completion date • Hematological Disorders • Hematological Malignancies • Oncology
February 27, 2023
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
(clinicaltrials.gov)
- P1/2 | N=34 | Active, not recruiting | Sponsor: Cancer Vaccines Limited | Recruiting ➔ Active, not recruiting | Trial completion date: Feb 2024 ➔ Feb 2025 | Trial primary completion date: Apr 2023 ➔ Apr 2024
Enrollment closed • Trial completion date • Trial primary completion date • Hematological Disorders • Hematological Malignancies • Oncology
1 to 3
Of
3
Go to page
1